Gene · 7917
Papers1,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy. | Cancer Res Commun | 2023 | 37520743 | PubTator, text mining | PubMed |
| Single-cell genomics in acquired bone marrow failure syndromes. | Blood | 2023 | 37478398 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy. | Biomolecules | 2023 | 37371477 | PubTator, text mining | PubMed |
| A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma. | BMC Musculoskelet Disord | 2023 | 37353812 | PubTator, text mining | PubMed |
| Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer. | Front Immunol | 2023 | 37346034 | PubTator, text mining | PubMed |
| Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints. | Cancers (Basel) | 2023 | 37345111 | PubTator, text mining | PubMed |
| Mechanisms of readthrough mitigation reveal principles of GCN1-mediated translational quality control. | Cell | 2023 | 37339632 | PubTator, text mining | PubMed |
| Noncoding translation: Quality control in the BAG. | Mol Cell | 2023 | 37327774 | PubTator, text mining | PubMed |
| New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review). | Int J Oncol | 2023 | 37326100 | PubTator, text mining | PubMed |
| Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. | J Ovarian Res | 2023 | 37322531 | PubTator, text mining | PubMed |
| C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EMBO Rep | 2023 | 37317656 | PubTator, text mining | PubMed |
| Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression. | Microorganisms | 2023 | 37317092 | PubTator, text mining | PubMed |
| N-terminal proteoforms may engage in different protein complexes. | Life Sci Alliance | 2023 | 37316325 | PubTator, text mining | PubMed |
| SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. | Front Cell Dev Biol | 2023 | 37313439 | PubTator, text mining | PubMed |
| Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development. | Acta Pharm | 2023 | 37307368 | PubTator, text mining | PubMed |
| Genome-Wide Screening in Human Embryonic Stem Cells Highlights the Hippo Signaling Pathway as Granting Synthetic Viability in ATM Deficiency. | Cells | 2023 | 37296624 | PubTator, text mining | PubMed |
| Compilation and functional classification of telomere length-associated genes in humans and other animal species. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37293446 | PubTator, text mining | PubMed |
| Extracellular vesicle-based drug delivery in cancer immunotherapy. | Drug Deliv Transl Res | 2023 | 37261603 | PubTator, text mining | PubMed |
| Rational Chemical Design of Molecular Glue Degraders. | ACS Cent Sci | 2023 | 37252349 | PubTator, text mining | PubMed |
| NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | 37228595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7917/papers?page=7